NCT00216528View on ClinicalTrials.gov

A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres

PHASE4CompletedINTERVENTIONAL

Enrollment

527

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

April 30, 2007

Conditions

Schizophrenia

Interventions

DRUG

risperidone

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT00216528 - A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres | Biotech Hunter | Biotech Hunter